Cytokinetics Inc (CYTK) — Cash Flow-to-Debt Ratio
Cytokinetics Inc (CYTK) has a Cash Flow-to-Debt Ratio of -0.07x as of March 2026, meaning its operating cash flow of $-145.46 Million could theoretically repay 0% of its total liabilities ($2.10 Billion) in one year. See Cytokinetics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cytokinetics Inc Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Cytokinetics Inc across 24 annual periods. Also explore Cytokinetics Inc (CYTK) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Cytokinetics Inc (2002–2025)
Year-by-year debt coverage analysis for Cytokinetics Inc. For market capitalisation and broader financial context, see Cytokinetics Inc (CYTK) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.24x | $-510.01 Million | $2.08 Billion | ▲ +5.0% |
| 2024 | -0.26x | $-395.89 Million | $1.54 Billion | ▲ +24.7% |
| 2023 | -0.34x | $-414.33 Million | $1.21 Billion | ▼ -28.3% |
| 2022 | -0.27x | $-299.52 Million | $1.12 Billion | ▼ -11.8% |
| 2021 | -0.24x | $-142.52 Million | $597.46 Million | ▼ -1221.4% |
| 2020 | 0.02x | $8.94 Million | $420.42 Million | ▲ +107.0% |
| 2019 | -0.30x | $-90.91 Million | $300.75 Million | ▲ +44.7% |
| 2018 | -0.55x | $-101.22 Million | $185.24 Million | ▲ +0.7% |
| 2017 | -0.55x | $-101.76 Million | $184.97 Million | ▼ -212.7% |
| 2016 | 0.49x | $36.98 Million | $75.78 Million | ▲ +366.2% |
| 2015 | 0.10x | $4.88 Million | $46.65 Million | ▲ +109.5% |
| 2014 | -1.10x | $-44.84 Million | $40.90 Million | ▼ -308.3% |
| 2013 | -0.27x | $-7.72 Million | $28.75 Million | ▲ +95.1% |
| 2012 | -5.47x | $-33.44 Million | $6.11 Million | ▲ +44.9% |
| 2011 | -9.92x | $-45.59 Million | $4.59 Million | ▼ -65.5% |
| 2010 | -6.00x | $-44.83 Million | $7.48 Million | ▼ -1608.4% |
| 2009 | 0.40x | $8.42 Million | $21.17 Million | ▲ +124.4% |
| 2008 | -1.63x | $-61.33 Million | $37.69 Million | ▼ -2902.9% |
| 2007 | -0.05x | $-3.00 Million | $55.45 Million | ▲ +92.7% |
| 2006 | -0.75x | $-47.17 Million | $63.20 Million | ▲ +66.2% |
| 2005 | -2.21x | $-39.48 Million | $17.90 Million | ▼ -33.2% |
| 2004 | -1.66x | $-34.03 Million | $20.55 Million | ▼ -740.9% |
| 2003 | -0.20x | $-30.51 Million | $154.90 Million | ▼ -3.1% |
| 2002 | -0.19x | $-22.30 Million | $116.76 Million | — |